Brian Wakabayashi

Brian Wakabayashi has a diverse work experience in finance and accounting roles. Brian is currently the Vice President of Finance and Accounting at 4D Molecular Therapeutics, where they are responsible for various financial functions and has assisted in public offerings. From 2011 to 2021, they worked at Gilead Sciences, initially as the Executive Director of R&D Finance, overseeing a large budget, and later as the Director of Manufacturing Finance. Prior to that, from 2007 to 2011, they held the position of Associate Director at Genentech. Brian also has experience as the Vice President of Finance, Human Resources, and Legal at INFINITI SOLUTIONS USA, where they were responsible for financial reporting and forecasting.

Brian Wakabayashi attended UCLA where they earned a Bachelor of Arts degree in Economics-Business. Brian later attended the UCLA Anderson School of Management, where they obtained a Master of Business Administration (MBA) degree. No specific start or end years were provided for either of their educational experiences.